Physician profile
Todd E Laughner
NPI 1982750170
$869.78
in general payments reported to CMS, 2019-2025
13 companies · $93.34 in 2025
The $93.34 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $35.60 · 2021: $57.08 · 2022: $91.08 · 2023: $183 · 2024: $136 · 2025: $93.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $200.27 | 2019-2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $133.21 | 2019 | |
| Amgen INC. | $122.56 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $77.35 | 2019-2025 | Puraply, Cygnus Dual |
| Smith+Nephew, INC. | $63.46 | 2021-2025 | Collagenase Santyl |
| Stryker Corporation | $57.88 | 2023 | Ortholoc 3di Crosscheck, Augment Injectable, Actishield |
| Bioventus LLC | $54.53 | 2020-2022 | |
| Treace Medical Concepts, INC. | $44.38 | 2022-2024 | |
| Convatec INC. | $31.99 | 2023 | |
| Abbott Laboratories | $25.62 | 2023 | Prodigy |
| Wright Medical Technology, INC. | $24.99 | 2019 | |
| Depuy Synthes Sales INC. | $18.68 | 2024 | Na |
| Kerecis Limited | $14.86 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Laughner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.